The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | The management of patients with ET or PV during pregnancy
Mary Frances McMullin, MD, Queen’s University, Belfast, UK, discusses the management of patients with essential thrombocythemia (ET) or polycythemia vera (PV) during pregnancy, emphasizing the importance of low-dose aspirin and the careful monitoring of placental blood flow. Prof. McMullin highlights the need for individualized multi-disciplinary management, including careful planning of delivery and postpartum care. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
